Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00306085|
Recruitment Status : Unknown
Verified March 2006 by University of Naples.
Recruitment status was: Recruiting
First Posted : March 22, 2006
Last Update Posted : March 22, 2006
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Vascular Diseases||Genetic: Autologous bone marrow cells||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis|
|Study Start Date :||April 2005|
|Study Completion Date :||April 2006|
- Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.
- Angiographic and laser doppler measurements after six months from treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00306085
|Contact: Heidi Eisele||+39 email@example.com|
|University of Naples||Recruiting|
|Naples, Italy, 80134|
|Contact: Maria Carmela Corbisiero +39081/5665681 firstname.lastname@example.org|
|Study Director:||Vincenzo Sica||University of Naples|